Increased lung preproET-1 and decreased ET(B)-receptor gene expression in fetal pulmonary hypertension

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 4 18-4, 1998, Pages

  Ivy, D Dunbar ^a,b   Le Cras, Timothy D ^a   Horan, Marilee P ^a   Abman, Steven H ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Endothelin; Endothelin receptors; Endothelin converting enzyme; Fetus; Persistent pulmonary hypertension of the newborn; Pulmonary circulation

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN B RECEPTOR; MESSENGER RNA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DUCTUS ARTERIOSUS; FETUS; FETUS LUNG; GENE EXPRESSION; LUNG VASCULAR RESISTANCE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION;

EID: 0031965759     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.4.l535     Document Type: Article

References (52)

1. Abman, S. H., P. F. Shanley, and F. J. Accurso. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J. Clin. Invest. 83: 1849-1858, 1989.
2. Allen, S. W., B. A. Chatfield, S. A. Koppenhafer, M. S. Schaffer, R. R. Wolfe, and S. H. Abman. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity. Am. Rev. Respir. Dis. 148: 519-522, 1993.
3. Belik, J., A. J. Halayko, K. Rao, and N. L. Stephens. Fetal ductus arteriosus ligation. Pulmonary vascular smooth muscle biochemical and mechanical changes. Circ. Res. 72: 588-596, 1993.
4. A-receptor antagonist, attenuates hypoxic pulmonary hypertension in rats. Am. J. Physiol. 266 (Heart Circ. Physiol. 35): H1327-H1331, 1994.
5. Cacoub, P., R. Dorent, G. Maistre, P. Nataf, A. Carayon, C. Piette, P. Godeau, C. Cabrol, and I. Gandjbakhch. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am. J. Cardiol. 71: 448-450, 1993.
6. Cassin, S., V. Kristova, T. Davis, P. Kadowitz, and G. Gause. Tone-dependent responses to endothelin in the isolated perfused fetal sheep pulmonary circulation in situ. J. Appl. Physiol. 70: 1228-1234, 1991.
7. Chatfield, B. A., I. F. McMurtry, S. L. Hall, and S. H. Abman. Hemodynamic effects of endothelin-1 on ovine fetal pulmonary circulation. Am. J. Physiol. 261 (Renal Fluid Electrolyte Physiol. 30): R182-R187, 1991.
8. Chen, S. J., Y. F. Chen, Q. C. Meng, J. Durand, V. S. DiCarlo, and S. Oparil. Endothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in rats. J. Appl. Physiol. 79: 2122-2131, 1995.
9. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
10. Coceani, F., and L. Kelsey. Endothelin-1 release from lamb ductus arteriosus: relevance to postnatal closure of the vessel. Can. J. Physiol. Pharmacol. 69: 218-221, 1991.
11. A-receptor antagonist prevents and reverses chronic hypoxia-induced pulmonary hypertension in rat. Am. J. Physiol. 269 (Lung Cell. Mol. Physiol. 13): L690-L697, 1995.
12. Donahue, D. M., M. E. Lee, H. C. Suen, T. Quertermous, and J. C. Wain. Pulmonary hypoxia increases endothelin-1 gene expression in sheep. J. Surg. Res. 57: 280-283, 1994.
13. Eddahibi, S., B. Raffestin, P. Braquet, P. E. Chabrier, and S. Adnot. Pulmonary vascular reactivity to endothelin-1 in normal and chronically pulmonary hypertensive rats. J. Cardiovasc. Pharmacol. 7, Suppl. 7: S358-S361, 1991.
14. Emoto, N., and M. Yanagisawa. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J. Biol. Chem. 270: 15262-15268, 1995.
15. Giaid, A., M. Yanagisawa, D. Langleben, R. P. Michel, R. Levy, H. Shennib, S. Kimura, T. Masaki, W. P. Duguid, and D. J. Stewart. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328: 1732-1739, 1993.
16. Gosselin, R., J. Gutkowska, J. Baribeau, and T. Perreault. Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L72-L79, 1997.
17. Ikura, T., T. Sawamura, T. Shiraki, H. Hosokawa, T. Kido, H. Hoshikawa, K. Shimada, K. Tanzawa, S. Kobayashi, and S. Miwa. cDNA cloning and expression of bovine endothelin converting enzyme. Biochem. Biophys. Res. Commun. 203: 1417-1422, 1994.
18. Ivy, D. D., J. P. Kinsella, and S. H. Abman. Endothelin blockade augments pulmonary vasodilation in the ovine fetus. J. Appl. Physiol. 81: 2481-2487, 1996.
19. Ivy, D. D., J. P. Kinsella, and S. H. Abman. Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J. Clin. Invest. 93: 2141-2148, 1994.
20. Ivy, D. D., T. A. Parker, J. W. Ziegler, H. L. Galan, J. P. Kinsella, R. M. Tuder, and S. H. Abman. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J. Clin. Invest. 99: 1179-1186, 1997.
21. Ivy, D. D., J. W. Ziegler, M. F. Dubus, J. J. Fox, J. P. Kinsella, and S. H. Abman. Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr. Res. 39: 435-442, 1996.
22. Jones, O. W., and S. H. Abman. Systemic and pulmonary hemodynamic effects of big endothelin-1 and phosphoramidon in the ovine fetus. Am. J. Physiol. 266 (Renal Fluid Electrolyte Physiol. 35): R929-R955, 1994.
23. Kiowski, W., G. Sutsch, P. Hunziker, P. Muller, J. Kim, E. Oechslin, R. Schmitt, R. Jones, and O. Bertel. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346: 732-736, 1995.
24. Komai, H., I. T. Adatia, M. J. Elliott, M. R. de Leval, and S. G. Haworth. Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease. J. Thorac. Cardiovasc. Surg. 106: 473-478, 1993.
25. Kourembanas, S., L. P. McQuillan, G. K. Leung, and D. V. Faller. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J. Clin. Invest. 92: 99-104, 1993.
26. Levin, D. L., M. A. Heymann, J. A. Kitterman, G. A. Gregory, R. H. Phibbs, and A. M. Rudolph. Persistent pulmonary hypertension of the newborn infant. J. Pediatr. 89: 626-630, 1976.
27. Li, H., T. S. Elton, Y. F. Chen, and S. Oparil. Increased endothelin receptor gene expression in hypoxic rat lung. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L553-L560, 1994.
28. Liben, S., D. J. Stewart, J. De Marte, and T. Perreault. Ontogeny of Big endothelin-1 effects in newborn piglet pulmonary vasculature. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H139-H145, 1993.
29. Lippton, H. L., G. A. Cohen, I. F. McMurtry, and A. L. Hyman. Pulmonary vasodilation to endothelin isopeptides in vivo is mediated by potassium channel activation. J. Appl. Physiol. 70: 947-952, 1991.
30. MacCumber, M. W., C. A. Ross, B. M. Glaser, and S. H. Snyder. Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action. Proc. Natl. Acad. Sci. USA 86: 7285-7289, 1989.
31. McQueston, J. A., J. P. Kinsella, D. D. Ivy, I. F. McMurtry, and S. H. Abman. Chronic pulmonary hypertension in utero impairs endothelium-dependent vasodilation. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H288-H294, 1995.
32. Miyauchi, T., R. Yorikane, S. Sakai, T. Sakurai, M. Okada, M. Nishikibe, M. Yano, I. Yamaguchi, Y. Sugishita, and K. Goto. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ. Res. 73: 887-897, 1993.
33. Morin, F. C., III. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr. Res. 25: 245-250, 1989.
34. Murphy, J. D., M. Rabinovitch, J. D. Goldstein, and L. M. Reid. The structural basis of persistent pulmonary hypertension of the newborn infant. J. Pediatr. 98: 962-967, 1981.
35. Nakamura, T., K. Kasai, S. Konuma, T. Emoto, N. Banba, M. Ishikawa, and S. Shimoda. Immunoreactive endothelin concentrations in maternal and fetal blood. Life Sci. 46: 1045-1050, 1990.
36. Perreault, T., and J. Baribeau. Characterization of endothelin receptors in newborn piglet lung. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L607-L614, 1995.
37. Rosenberg, A. A., J. Kennaugh, S. L. Koppenhafer, M. Loomis, B. A. Chatfield, and S. H. Abman. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J. Pediatr. 123: 109-114, 1993.
38. Shaul, P. W., I. S. Yuhanna, Z. German, Z. Chen, R. H. Steinhorn, and F. C. Morin III. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L1005-L1012, 1997.
39. Shimada, K., M. Takahashi, M. Ikeda, and K. Tanzawa. Identification and characterization of two isoforms of an endothelin-converting enzyme-1. FEBS Lett. 371: 140-144, 1995.
40. Stelzner, T. J., R. F. O'Brien, M. Yanagisawa, T. Sakurai, K. Sato, S. Webb, M. Zamora, I. F. McMurtry, and J. H. Fisher. Increased lung endothelin-1 production in rats with idiopathic pulmonary hypertension. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L614-L620, 1992.
41. ω-nitro-L-arginine in fetal lambs. J. Appl. Physiol. 72: 1730-1734, 1992.
42. Valdenaire, O., E. Rohrbacher, and M. G. Mattei. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J. Biol. Chem. 270: 29794-29798, 1995.
43. Villamor, E., T. D. Le Cras, M. P. Horan, A. C. Halbower, R. M. Tuder, and S. H. Abman. Chronic intrauterine pulmonary hypertension impairs endothelial nitric oxide synthase in the ovine fetus. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L1013-L1020, 1997.
44. Vincent, J. A., R. D. Ross, J. Kassab, J. M. Hsu, and W. W. Pinsky. Relation of elevated plasma endothelin in congenital heart disease to increased pulmonary blood flow. Am. J. Cardiol. 71: 1204-1207, 1993.
45. Wagner, O. F., G. Christ, J. Wojta, H. Vierhapper, S. Parzer, P. J. Nowotny, B. Schneider, W. Waldhausl, and B. R. Binder. Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 267: 16066-16068, 1992.
46. Wang, Y., and F. Coceani. Isolated pulmonary resistance vessels from fetal lambs. Contractile behavior and responses to indomethacin and endothelin-1. Circ. Res. 71: 320-330, 1992.
47. Wong, J., J. R. Fineman, and M. A. Heymann. The role of endothelin and endothelin receptor subtypes in regulation of fetal pulmonary vascular tone. Pediatr. Res. 35: 664-670, 1994.
48. Wong, J., P. A. Vanderford, J. R. Fineman, R. Chang, and S. J. Soifer. Endothelin-1 produces pulmonary vasodilation in the intact newborn lamb. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H1318-H1325, 1993.
49. Xu, D., N. Emoto, A. Giaid, C. Slaughter, S. Kaw, D. deWit, and M. Yanagisawa. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994.
50. Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
51. Yorikane, R., T. Miyauchi, S. Sakai, T. Sakurai, I. Yamaguchi, Y. Sugishita, and K. Goto. Altered expression of ETB-receptor mRNA in the lung of rats with pulmonary hypertension. J. Cardiovasc. Pharmacol. 2, Suppl. 8: S336-S338, 1993.
52. Zamora, M. A., E. C. Dempsey, S. J. Walchak, and T. J. Stelzner. BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 9: 429-433, 1993.